UB Paderborn / Katalog / Suche / in CDI

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.425

2008

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe

Arteriosclerosis, thrombosis, and vascular biology, 2010-03, Vol.30 (3), p.403

2010

Link zum Volltext

Verfügbarkeit prüfen

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents

Investigative radiology, 2015-08, Vol.50 (8), p.473-480

2015

Link zum Volltext

Verfügbarkeit prüfen

Transcatheter embolization therapy in liver cancer： an update of clinical evidences

Chinese journal of cancer research, 2015-04, Vol.27 (2), p.96-121

2015

Link zum Volltext

Verfügbarkeit prüfen

Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis

Molecular pharmacology, 2005-06, Vol.67 (6), p.1966-1976

2005

Link zum Volltext

Verfügbarkeit prüfen

Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats

Investigative radiology, 2017-05, Vol.52 (5), p.255-264

2017

Link zum Volltext

Verfügbarkeit prüfen

Gadolinium-based contrast agents targeted to amyloid aggregates for the early diagnosis of Alzheimer's disease by MRI

European journal of medicinal chemistry, 2014-11, Vol.87, p.843-861

2014

Link zum Volltext

Verfügbarkeit prüfen

Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model

Radiology, 2020-01, Vol.294 (1), p.117-126

2020

Link zum Volltext

Verfügbarkeit prüfen

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review

Toxicology (Amsterdam), 2008-06, Vol.248 (2), p.77-88

2008

Link zum Volltext

Verfügbarkeit prüfen

Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques

Molecular pharmaceutics, 2009-12, Vol.6 (6), p.1903-1919

2009

Link zum Volltext

Verfügbarkeit prüfen

Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives

Arteriosclerosis, thrombosis, and vascular biology, 2012-06, Vol.32 (6), p.e36

2012

Link zum Volltext

Verfügbarkeit prüfen

Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe

Journal of medicinal chemistry, 2009-08, Vol.52 (15), p.4725-4742

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Cellular Targets of the MRI Contrast Agent P947 for Atherosclerosis Imaging

Molecular pharmaceutics, 2012-04, Vol.9 (4), p.850-861

2012

Link zum Volltext

Verfügbarkeit prüfen

Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers

Molecular pharmacology, 2005-02, Vol.67 (2), p.460-469

2005

Link zum Volltext

Verfügbarkeit prüfen

Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint

Quantitative imaging in medicine and surgery, 2013-12, Vol.3 (6), p.292-297

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting

Magnetic resonance in medicine, 2008-12, Vol.60 (6), p.1337-1346

2008

Link zum Volltext

Verfügbarkeit prüfen

Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI

European radiology, 2013-01, Vol.23 (1), p.37-47

2013

Link zum Volltext

Verfügbarkeit prüfen

Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC

Contrast media and molecular imaging, 2016-05, Vol.11 (3), p.211-221

2016

Link zum Volltext

Verfügbarkeit prüfen

In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties

Contrast media and molecular imaging, 2011-07, Vol.6 (4), p.236-250

2011

Link zum Volltext

Verfügbarkeit prüfen

The TXP Motif in the Second Transmembrane Helix of CCR5

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13217-13225

2001

Link zum Volltext

Verfügbarkeit prüfen

Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”

Journal of surgery and medicine, 2019-08

2019

Link zum Volltext

Verfügbarkeit prüfen

Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC: MRI Contrast Agent Targeting MUC5AC

Contrast media and molecular imaging, 2016-05, Vol.11 (3), p.211-221

2016

Link zum Volltext

Verfügbarkeit prüfen

The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13217-13225

2001

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer Models

Journal of vascular and interventional radiology, 2018-03, Vol.29 (3), p.413-424

2018

Link zum Volltext

Verfügbarkeit prüfen

Comment on “In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma”

Molecular pharmaceutics, 2018-01, Vol.15 (1), p.332-335

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach

Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents

Transcatheter embolization therapy in liver cancer： an update of clinical evidences

Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis

Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats

Gadolinium-based contrast agents targeted to amyloid aggregates for the early diagnosis of Alzheimer's disease by MRI

Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review

Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques

Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives

Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe

Molecular and Cellular Targets of the MRI Contrast Agent P947 for Atherosclerosis Imaging

Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers

Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint

Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting

Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI

Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC

In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties

The TXP Motif in the Second Transmembrane Helix of CCR5

Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”

Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC: MRI Contrast Agent Targeting MUC5AC

The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation

Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer Models

Comment on “In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma”

Suchergebnisse filtern